TCF-4 Antibodies

Santa Cruz Biotechnology delivers a wide array of TCF-4 monoclonal antibodies for research focused on understanding TCF-4's role in various biological processes. The monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). TCF-4, also known as Transcription Factor 7-Like 2 (TCF7L2), is a key player in the Wnt signaling pathway, which is crucial for cell proliferation, differentiation, and development. TCF-4 has been implicated in various physiological processes and is associated with several diseases, including cancer and diabetes. Understanding TCF-4's function is essential for elucidating its role in disease progression and for developing targeted therapeutic strategies. Researchers can utilize TCF-4 monoclonal antibodies to investigate protein expression patterns across different tissue types. Advanced imaging techniques combined with TCF-4 monoclonal antibodies enable visualization of protein localization within cellular compartments. Multiple detection methods can be employed to study TCF-4's interactions with other proteins and its involvement in signaling cascades. Santa Cruz Biotechnology monoclonal antibodies for TCF-4 support researchers worldwide in advancing scientific understanding of cellular regulation and disease mechanisms.